(-0.07%) 5 096.40 points
(0.11%) 38 283 points
(-0.08%) 15 916 points
(-1.37%) $82.70
(5.93%) $2.04
(0.10%) $2 349.50
(-0.24%) $27.47
(3.77%) $956.85
(-0.20%) $0.933
(-0.29%) $10.99
(-0.51%) $0.796
(1.74%) $93.47
1.85% $ 22.60
Live Chart Being Loaded With Signals
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States...
Stats | |
---|---|
Tagesvolumen | 110.00 |
Durchschnittsvolumen | 14 445.00 |
Marktkapitalisierung | 484.52M |
EPS | $-0.178 ( 2023-09-29 ) |
Last Dividend | $0.555 ( 2023-10-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.02 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-13 | Schreiber Justin | Buy | 50 000 | Common Stock |
2023-11-06 | Jindal Piyush | Buy | 37 500 | Common Stock |
2023-11-06 | Jindal Piyush | Sell | 37 500 | Stock Option (Right to Buy) |
2023-06-13 | Velge Bertrand | Buy | 49 465 | Common Stock |
2023-06-07 | Velge Bertrand | Buy | 24 500 | Common Stock |
INSIDER POWER |
---|
42.69 |
Last 50 transactions |
Buy: 2 415 167 | Sell: 887 500 |
LifeMD, Inc. Korrelation
10 Am meisten positiv korreliert | |
---|---|
UCL | 0.831 |
PLRX | 0.83 |
PALT | 0.829 |
SOHO | 0.822 |
XBIO | 0.816 |
YTEN | 0.815 |
NVFY | 0.803 |
DCGO | 0.801 |
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
LifeMD, Inc. Finanzdaten
Annual | 2023 |
Umsatz: | $152.55M |
Bruttogewinn: | $126.01M (82.61 %) |
EPS: | $-0.610 |
FY | 2023 |
Umsatz: | $152.55M |
Bruttogewinn: | $126.01M (82.61 %) |
EPS: | $-0.610 |
FY | 2022 |
Umsatz: | $119.03M |
Bruttogewinn: | $100.37M (84.32 %) |
EPS: | $-1.450 |
FY | 2021 |
Umsatz: | $92.88M |
Bruttogewinn: | $74.88M (80.62 %) |
EPS: | $-0.00229 |
Financial Reports:
No articles found.
LifeMD, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.622 | 2022-01-03 |
Last Dividend | $0.555 | 2023-10-05 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-16 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | $4.51 | -- |
Avg. Dividend % Per Year | 7.37% | -- |
Score | 5.92 | -- |
Div. Sustainability Score | 6.99 | |
Div.Growth Potential Score | 2.29 | |
Div. Directional Score | 4.64 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $2.29 | 12.40% |
2023 | $2.22 | 15.90% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.175 | 1.500 | -3.50 | -5.25 | [0 - 0.5] |
returnOnAssetsTTM | -0.456 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 3.88 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | -0.116 | -1.000 | -1.165 | 1.165 | [0 - 1] |
currentRatioTTM | 1.225 | 0.800 | 8.88 | 7.10 | [1 - 3] |
quickRatioTTM | 1.105 | 0.800 | 8.21 | 6.57 | [0.8 - 2.5] |
cashRatioTTM | 0.953 | 1.500 | 5.82 | 8.73 | [0.2 - 2] |
debtRatioTTM | 0.322 | -1.500 | 4.63 | -6.94 | [0 - 0.6] |
interestCoverageTTM | -5.58 | 1.000 | -3.18 | -3.18 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.240 | 2.00 | 9.92 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00237 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 5.38 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.863 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0950 | 1.000 | -3.90 | -3.90 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.468 | 1.000 | 8.51 | 8.51 | [0.2 - 2] |
assetTurnoverTTM | 2.61 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 6.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -16.45 | 1.000 | -1.762 | 0 | [1 - 100] |
returnOnEquityTTM | 3.88 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00237 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.240 | 2.00 | 9.92 | 10.00 | [0 - 30] |
payoutRatioTTM | -0.116 | 1.500 | -1.165 | 1.165 | [0 - 1] |
pegRatioTTM | 0.250 | 1.500 | -1.668 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0578 | 1.000 | -1.055 | 0 | [0.1 - 0.5] |
Total Score | 2.29 |
LifeMD, Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.